Seattle biotech firm Impel NeuroPharma files for $75M IPO
Impel CEO Adrian Adams. (Impel Photo) Seattle-based biotech company Impel NeuroPharma is set to go
Read the full article at contacted.org...
Found and curated by
Impel CEO Adrian Adams. (Impel Photo) Seattle-based biotech company Impel NeuroPharma is set to go
Read the full article at contacted.org...
Found and curated by
Comments
Post a Comment